NPM1基因突变与急性髓细胞白血病
摘要
NPM1(Nucleophosmin,又称B23、Numatrin或N038)是一种主要的核仁磷酸化蛋白,其定位于核仁的颗粒区,具有重要的肿瘤抑制作用。近一年来的研究发现NPM1基因第12号外显子的突变是急性髓细胞白血病(AML),尤其是正常核型AML中最常见的一种分子遗传学异常,且与其发病密切相关。对NPM1基因突变的深入研究在AML患者的疗效预测、预后判断及靶向治疗中有着重要的临床意义。
出处
《国际输血及血液学杂志》
CAS
2007年第3期246-249,共4页
International Journal of Blood Transfusion and Hematology
参考文献21
-
1Chan PK, Chan FY, Morris SW, et al. Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5' enhancer region. Nucleic Acids Res, 1997, 25 (6) : 1225-1232.
-
2项佑贵,陆顺元,顾鸣敏,王升跃,任双喜,傅刚,王铸钢.小鼠Nucleophosmin基因的克隆及基因组结构分析[J].Acta Genetica Sinica,2005,32(6):641-649. 被引量:1
-
3Nishimura Y, Ohkubo T, Furuichi Y, et al. Tryptophans 286 and 288 in the C-terminal region of protein B23.1 are important for its nucleolar localization. Biosci Biotechnol Biochem, 2002, 66(10): 2239-2242.
-
4Okuda M, Horn HF, Tarapore P, et al. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell, 2000, 103(1 ) :127-140.
-
5Falini B, Mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med, 2005, 352(3):254-266.
-
6Dohner K, Schlenk RF, Habdank M, et al. Mutant nucleophosmin (NPMI) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood, 2005, 106 (12) : 3740-3746.
-
7Cazzaniga G, Dell'Oro MG, Mecucci C, et al. Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood, 2005, 106(4):1419-1422.
-
8Verhaak RGW, Goudswaard CS, Putten WV, et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML) association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood, 2005,106(12):3747-3754.
-
9Jaju RJ, Haas OA, Neat M, et al. A new recurrent translocation, t (5 ; 11 ) (q35 ; p 15.5 ), associated with del (5q) in childhood acute leukemia. Blood, 1999,94(2):773-780.
-
10Thiede G, Koch S, Creutzig E, et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood, 2006,107(10):4011-4020.
二级参考文献15
-
1Chou Y H,Yung B Y.Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin/B23.Biochem Biophys Res Commun,1995,217(1):313~325.
-
2Szebeni A,Olson M O.Nucleolar protein B23 has molecular chaperone activities.Protein Sci,1999,8(4):905~912.
-
3Okuwaki M,Matsumoto K,Tsujimoto M,Nagata K.Function of nucleophosmin/B23,a nucleolar acidic protein,as a histone chaperone.FEBS Lett,2001,506(3):272~276
-
4Okuda M,Horn H F,Tarapore P,Tokuyama Y,Smulian A G,Chan P K,Knudsen E S,Hofmann I A,Snyder J D,Bove K E,Fukasawa K.Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.Cell,2000,103(1):127~140.
-
5Colombo E,Marine J C,Danovi D,Falini B,Pelicci P G.Nucleophosmin regulates the stability and transcriptional acti-vity of p53.Nat Cell Biol,2002,4(7):529~533.
-
6Slupianek A,Nieborowska-Skorska M,Hoser G,Morrione A,Majewski M,Xue L,Morris S W,Wasik M A,Skorski T.Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis.Cancer Res,2001,61(5):2194~2199.
-
7Yoneda-Kato N,Look A T,Kirstein M N,Valentine M B,Raimondi S C,Cohen K J,Carroll A J,Morris S W.The t (3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene,NPM-MLF1.Oncogene,1996,12(2):265~275.
-
8Redner R L,Rush E A,Faas S,Rudert W A,Corey S J.The t (5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.Blood,1996,87(3):882~886.
-
9Chan W Y,Liu Q R,Borjigin J,Busch H,Rennert O M,Tease L A,Chan P K.Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth.Biochemistry,1989,28(3):1033~1039.
-
10Xin J H,Cowie A,Lachance P,Hassell J A.Molecular cloning and characterization of PEA3,a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells.Genes Dev,1992,6(3):481~496.
-
1邹积艳,朱平,张立鹏,刘红星.伴有NPM1基因突变的急性髓细胞白血病患者的临床特征[J].中华临床医师杂志(电子版),2010,4(11):43-47. 被引量:3
-
2俞罡,陈静桂.急性髓系白血病患者FLT3-ITD和NPM1基因突变表达及在判断预后中的意义[J].临床和实验医学杂志,2015,14(7):565-568. 被引量:7
-
3陈华英,鹿全意.急性髓系白血病NPM1基因突变研究[J].中国实验血液学杂志,2013,21(1):258-262. 被引量:7
-
4李明,汤爱萍,余莉,李慧慧,费妍.NPM1基因在急性髓细胞白血病中的表达及其临床意义[J].重庆医学,2012,41(20):2015-2017. 被引量:2
-
5朱柏贵,张苏江,李建勇.NPM1基因突变在急性髓系白血病中的作用[J].武警医学,2010,21(7):575-577.
-
6王良妥,张湘兰,司徒健瑜,黄远颖.慢性粒细胞白血病患者Wnt5a基因及NPM1基因的表达及其意义[J].海南医学院学报,2015,21(10):1399-1401. 被引量:1
-
7李婷婷,孙雪冬,董征,余长林,孙琪云,乔建辉,胡锴勋,刘广贤,姚波,艾辉胜,郭梅.FLT3-ITD阳性与阴性急性髓细胞白血病的实验室特征及预后比较[J].解放军医学杂志,2013,38(6):501-505. 被引量:12
-
8高辉,张悦,肖志坚.核仁磷酸化蛋白基因与血液系统恶性肿瘤[J].白血病.淋巴瘤,2007,16(2):142-146. 被引量:1
-
9戴丹,张苏江,乔纯,孙雪梅,钱思轩,徐卫,徐燕丽,李建勇.急性髓系白血病NPM1基因突变的研究[J].中国实验血液学杂志,2009,17(2):294-297. 被引量:6
-
10张园园,李田兰,颜学申,毛春霞,刘珊珊,孟繁军.NPM1和FLT3基因突变的正常核型急性髓系白血病病人临床特征及预后分析[J].齐鲁医学杂志,2015,30(3):266-269. 被引量:2